Predicting Rheumatoid Arthritis Treatment Success New Biomarker Breakthrough Key Takeaways Rheumatoid arthritis is a chronic systemic autoimmune disease affecting approximately 1 percent of the global population. Despite major advances in biologic and targeted synthetic disease modifying antirheumatic drugs, treatment success remains highly variable. Approximately
Tag: antirheumatic drugs
